DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Summary for Patent: 10,017,768
|Title:||Method of treatment of chlamydial infections with selected EGFR inhibitors|
|Abstract:||The present invention provides compositions and methods of use in the treatment/prevention of chlamydial infection and/or diseases and disorders associated with chlamydial infection in a subject.|
|Inventor(s):||Tsang; Allen W. (Clemmons, NC), Furdui; Cristina M. (Clemmons, NC)|
|Assignee:||Wake Forest University Health Sciences (Winston-Salem, NC)|
|Patent Claims:||1. A method of treating a vaginal chlamydial infection or pelvic inflammatory disease in a subject, comprising administering to the subject an effective amount of Erlotinib,
Cetuximab, Gefitinib, Lapatinib, Canertinib, Vandetanib and any combination thereof.
2. The method of claim 1, further comprising administering to the subject an antibiotic, a chemotherapeutic agent, an anti-inflammatory agent, an immunomodulatory agent and/or radiation, in any combination.
|Applicant||Tradename||Biologic Ingredient||Dosage Form||BLA||Number||Approval Date||Patent No.||Assignee||Estimated Patent Expiration||Status||Orphan||Source|
|Imclone||ERBITUX||cetuximab||VIAL; INTRAVENOUS||125084||001||2004-06-18||⤷ Free Forever Trial||Wake Forest University Health Sciences (Winston-Salem, NC)||2033-09-13||RX||Orphan||search|
|>Applicant||>Tradename||>Biologic Ingredient||>Dosage Form||>BLA||>Number||>Approval Date||>Patent No.||>Assignee||>Estimated Patent Expiration||>Status||>Orphan||>Source|
|Country||Patent Number||Estimated Expiration|
|Canada||2923837||⤷ Free Forever Trial|
|European Patent Office||3043817||⤷ Free Forever Trial|
|Mexico||2016003293||⤷ Free Forever Trial|
|United States of America||2015079079||⤷ Free Forever Trial|
|United States of America||2017067059||⤷ Free Forever Trial|
|World Intellectual Property Organization (WIPO)||2015038755||⤷ Free Forever Trial|
|>Country||>Patent Number||>Estimated Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.